NCT06415331

Brief Summary

The purpose of this research was to study whether the additional application of a certain medical intervention making use of radiofrequencies (pulsed-radiofrequency) would reduce pain in patients with herniated disk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 14, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

May 10, 2024

Last Update Submit

May 15, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain severity

    Pain severity measured with the numeric rating scale (NRS). The numeric rating scale measures pain on a scale of 0-10 with 0 representing "no pain" and 10 representing "the worst pain possible".

    1 month after treatment

Study Arms (2)

Conventional therapy

ACTIVE COMPARATOR

Subjects in this arm received interventions which were conventional, including opioid and non-opioid analgesics, adjuvant analgesics, muscle relaxants, and physiotherapy.

Other: Conventional therapy

Conventional therapy + pulsed radiofrequency

EXPERIMENTAL

Subjects in this arm received pulsed radiofrequency in addition to the same conventional therapy as the other arm.

Procedure: Pulsed radiofrequencyOther: Conventional therapy

Interventions

Individualized dose of pulsed radiofrequency is given for 6 minutes.

Conventional therapy + pulsed radiofrequency

Conventional therapy for HNP consisting of: * Acetaminophen * NSAID: Etoricoxib, celecoxib, meloxicam, diclofenac, ibuprofen * Muscle relaxant: eperisone, diazepam * Opioid: codein, tramadol * Adjuvant analgesics: Amitriptyline, pregabalin, gabapentin * Physiotherapy: Short wave diathermy, ultrasound diathermy, transcutaneous electrical nerve stimulation, and exercise

Conventional therapyConventional therapy + pulsed radiofrequency

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having an established diagnosis of HNP
  • Complaint present for at least the pas 3 months
  • Experiencing pain intensity of 4 or greater on the numeric rating scale
  • Capable of giving informed consent

You may not qualify if:

  • Pregnant patients
  • Presence of infection at the site of pulsed radiofrequency
  • HNP with red flags.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Saiful Anwar Hospital

Malang, East Java, 65112, Indonesia

Location

MeSH Terms

Conditions

Pain

Interventions

Pulsed Radiofrequency Treatment

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRadiofrequency TherapyRehabilitation

Study Officials

  • Hana H Fachir, M.D.

    Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 16, 2024

Study Start

February 2, 2023

Primary Completion

July 14, 2023

Study Completion

September 16, 2023

Last Updated

May 17, 2024

Record last verified: 2024-05

Locations